JP2024513392A5 - - Google Patents
Info
- Publication number
- JP2024513392A5 JP2024513392A5 JP2023560497A JP2023560497A JP2024513392A5 JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5 JP 2023560497 A JP2023560497 A JP 2023560497A JP 2023560497 A JP2023560497 A JP 2023560497A JP 2024513392 A5 JP2024513392 A5 JP 2024513392A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163169538P | 2021-04-01 | 2021-04-01 | |
| US202163169533P | 2021-04-01 | 2021-04-01 | |
| US202163169527P | 2021-04-01 | 2021-04-01 | |
| US63/169,538 | 2021-04-01 | ||
| US63/169,533 | 2021-04-01 | ||
| US63/169,527 | 2021-04-01 | ||
| US202263325323P | 2022-03-30 | 2022-03-30 | |
| US63/325,323 | 2022-03-30 | ||
| PCT/US2022/022809 WO2022212696A1 (en) | 2021-04-01 | 2022-03-31 | Conjugated hepcidin mimetics |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024513392A JP2024513392A (ja) | 2024-03-25 |
| JPWO2022212696A5 JPWO2022212696A5 (https=) | 2025-03-06 |
| JP2024513392A5 true JP2024513392A5 (https=) | 2025-03-06 |
Family
ID=83456776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560497A Pending JP2024513392A (ja) | 2021-04-01 | 2022-03-31 | コンジュゲートされたヘプシジン模倣物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250277012A1 (https=) |
| EP (1) | EP4314017A4 (https=) |
| JP (1) | JP2024513392A (https=) |
| AU (1) | AU2022249095A1 (https=) |
| CA (1) | CA3213688A1 (https=) |
| TW (1) | TW202304951A (https=) |
| WO (1) | WO2022212696A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2968443T3 (da) | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| PT3143037T (pt) | 2014-05-16 | 2021-09-24 | Protagonist Therapeutics Inc | Antagonistas peptídicos tioéter de integrina alfa4beta7 |
| US9624268B2 (en) | 2014-07-17 | 2017-04-18 | Protagonist Therapeutics, Inc. | Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases |
| EP3749345A4 (en) | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| HRP20250769T1 (hr) | 2020-01-15 | 2025-08-29 | Janssen Biotech, Inc. | Peptidni inhibitori receptora za interleukin-23 i njihova uporaba u liječenju upalnih bolesti |
| AU2021209086A1 (en) | 2020-01-15 | 2022-08-04 | Janssen Biotech, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| AU2021383828A1 (en) | 2020-11-20 | 2023-07-06 | Janssen Pharmaceutica Nv | Compositions of peptide inhibitors of interleukin-23 receptor |
| WO2023288019A2 (en) | 2021-07-14 | 2023-01-19 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| EP4472996A4 (en) * | 2022-02-02 | 2025-11-26 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
| EP4472995A4 (en) * | 2022-02-02 | 2025-11-19 | Protagonist Therapeutics Inc | Conjugated hepcidin mimetics |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040152868A1 (en) * | 2001-03-30 | 2004-08-05 | Larsen Bjarne Due | Compositions and methods for modulating guanylyl cyclase signaling receptor (gc-c) activity and for treating meniere's disease |
| DK2968443T3 (da) * | 2013-03-15 | 2021-12-06 | Protagonist Therapeutics Inc | Hepcidinanaloger og anvendelser deraf |
| KR20170043509A (ko) * | 2014-06-27 | 2017-04-21 | 프로타고니스트 테라퓨틱스, 인코포레이티드 | 헵시딘 및 미니-헵시딘 유사체 및 그의 용도 |
| US20190002503A1 (en) * | 2015-12-30 | 2019-01-03 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| WO2018128828A1 (en) * | 2016-12-23 | 2018-07-12 | Bayer Healthcare Llc | Novel hepcidin mimetics and uses thereof |
| EP3749345A4 (en) * | 2018-02-08 | 2022-04-06 | Protagonist Therapeutics, Inc. | CONJUGATED HEPCIDIN MIMETICS |
| US20210061872A1 (en) * | 2019-09-03 | 2021-03-04 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| IL299530A (en) * | 2020-07-28 | 2023-02-01 | Protagonist Therapeutics Inc | Psidine is a conjugated mimetic |
-
2022
- 2022-03-31 AU AU2022249095A patent/AU2022249095A1/en active Pending
- 2022-03-31 WO PCT/US2022/022809 patent/WO2022212696A1/en not_active Ceased
- 2022-03-31 US US18/284,835 patent/US20250277012A1/en active Pending
- 2022-03-31 CA CA3213688A patent/CA3213688A1/en active Pending
- 2022-03-31 JP JP2023560497A patent/JP2024513392A/ja active Pending
- 2022-03-31 EP EP22782206.1A patent/EP4314017A4/en active Pending
- 2022-04-01 TW TW111112892A patent/TW202304951A/zh unknown